Carrie R. Willcox

2.7k citations
28 papers · 1.7k indexed · h-index 20

Carrie R. Willcox

26 papers receiving 1.7k citations

Peers

Carrie R. Willcox
Comparison fields: 5 of 76
  • Immunology 1.4k
  • Oncology 512
  • Epidemiology 192
  • Virology 26
  • Hematology 52
Replace Carmela La Mendola with:
Carmela La Mendola Italy
Anna M. Keller Netherlands
Mahboob Salim United Kingdom
Jaikumar Duraiswamy United States
Catherine Barbey Switzerland
Kelly‐Anne Masterman Australia
Linda Mark Sweden
Sanjeev Kumar Mendiratta India
Obinna Chijioke Switzerland
Sinéad M. Lougheed Netherlands
Carrie R. Willcox relative to Carmela La Mendola Italy Carmela La Mendola's profile →
Citations per field
00.5×3.6×
Carmela La Mendola · 1×
Citations per year

Countries citing papers authored by Carrie R. Willcox

Since Specialization
Citations

This map shows the geographic impact of Carrie R. Willcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie R. Willcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie R. Willcox more than expected).

Fields of papers citing papers by Carrie R. Willcox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie R. Willcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie R. Willcox. The network helps show where Carrie R. Willcox may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carrie R. Willcox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carrie R. Willcox Line = papers co-authored together Carrie R. Willcox links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 20250
3 20240
4 202326
5 202331
6 202225
7 2019113
8 201867
9 2018111
10 2018159
11 201819
12 201723
13 201715
14
Clonal selection in the human V delta 1 T cell repertoire indicates gamma delta TCR-dependent adaptive immune surveillance
201723
15 2017201
16 201739
17 201621
18 2012240
19 201182
20 200819

About Carrie R. Willcox

Carrie R. Willcox is a scholar working on Immunology, Oncology and Endocrinology, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (23 papers), Immune Cell Function and Interaction (22 papers), Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immune Response and Inflammation (3 papers), Cytomegalovirus and herpesvirus research (2 papers) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Immunology (1.4k citations), Oncology (512 citations) and Epidemiology (192 citations). Carrie R. Willcox has collaborated with scholars based in United Kingdom, Russia and United States. Frequent co-authors include Benjamin E. Willcox, Martin S. Davey, Fiyaz Mohammed, Mahboob Salim, Stuart Hunter, Dmitriy M. Chudakov, Sofya A. Kasatskaya, Adrian Hayday, Ye Htun Oo and Sonia Netzer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026